127
Views
2
CrossRef citations to date
0
Altmetric
Middle ear

Prognostic factors of early-onset otitis media with effusion in children treated using tympanostomy

ORCID Icon, , , , &
Pages 742-748 | Received 01 Jun 2021, Accepted 02 Jul 2021, Published online: 12 Aug 2021
 

Abstract

Background

Predicting the prognosis of early-onset otitis media with effusion (OME) in children is difficult.

Objectives

To investigate the prognostic factors of OME in children undergoing tympanostomy at 1 year of age.

Material and methods

We examined 66 children (123 ears) followed up to 6 years of age. OME prognosis was determined by a history of re-tympanostomy at the last examination. We retrospectively analysed the prognostic factors based on the duration of first ventilation tube (VT) placed, history of otorrhea, asthma, adenoidectomy, and mastoid air cell system (MACS) size at 1 year before tympanostomy and at 3 years.

Results

While 25 ears underwent re-tympanostomy (group 1), 98 did not (group 2). The mean duration of VT placed was 21 months and 25, and the mean MACS size at 3 years was 314 mm2 and 441, respectively, in the corresponding groups. MACS size at 3 years was significantly smaller in group 1 than in group 2. The combination of MACS size at 3 years and duration of VT placed showed the best value of area under the curve.

Conclusion and significance

The most probable prognostic factor was the combination of the MACS size at 3 years and duration of VT placed.

Chinese abstract

背景:对儿童早发性渗出性中耳炎(OME)预后的预测是比较困难的。

目的:探讨1岁OME儿童鼓膜造口术的预后因素。

材料和方法:我们检查了 66 名随访至 6 岁的儿童(123 只耳朵)。 OME 预后取决于最后一次检查时再次鼓膜造口术的病史。我们回顾性分析了放置第一次通气管 (VT) 的持续时间、耳漏病史、哮喘、腺样体切除术和鼓膜造口术前 1 年和 3 年时的乳突气囊系统 (MACS) 大小等预后因素。

结果:虽然 25 只耳朵接受了再次鼓膜造口术(第 1 组), 但 98 只没有(第 2 组)。 两组VT 的平均持续时间分别为 21 个月和 25 个月, 3 年的平均 MACS 大小分别为 314 mm2 和441 mm2。第 1 组中 3 年的 MACS 大小与第 2 组相比明显小很多。 3 年 MACS 大小和 VT 持续时间的组合显示最佳曲线下面积值。

结论和意义:最可能的预后因素是 3 年时MACS大小和VT 持续时间的组合。

Disclosure statement

The authors report no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.